Tradestie Institutional Equity Comparison Engine
UXI vs RXL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RXL Overall Edge
RXL Captures Institutional Edge (2โ0 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProShares Ultra Health Care (RXL) driven by superior Momentum & Technical, Options & Structure. Fundamentally, UXI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus RXL at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, UXI sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against RXL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
UXI N/M vs RXL N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
RXL
1Y +6.8% vs +42.0% ยท 52W Pos 32% vs 89%
Options & Structure Winner
RXL
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
UXI
NYSE Arca
ProShares Ultra Industrials
Institutional Equity
$49.27
-3.64% 1D
Market Cap
N/A
1M Return
-3.45%
1Y Return
+6.81%
Forward P/E
N/M
Unified AI Score
42.4 / 100
HOLD
Tech 48.0
Fund 59.0
Flow 50.0
Mom 54.0
RXL
NYSE Arca
ProShares Ultra Health Care
Institutional Equity
$71.98
-1.1% 1D
Market Cap
N/A
1M Return
+12.08%
1Y Return
+41.97%
Forward P/E
N/M
Unified AI Score
40.0 / 100
SELL
Tech 18.0
Fund 30.0
Flow 50.0
Mom 21.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
UXI +6.81%
RXL +41.97%
Spread: +31.67 pp (RXL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
UXI TTM Op. Margin: N/A
RXL TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UXI vs RXL. Trailing 12-month operating profitability (UXI N/A vs RXL N/A) and valuation multiples (UXI N/M vs RXL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | UXI | RXL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 32% ($42โ$65) | 89% ($43โ$76) | Stronger Trend | RXL |
| Beta / 30D Volatility Risk Regime | 1.92ฮฒ ยท 51% Vol | 0.54ฮฒ ยท 41% Vol | Lower Realized Risk | RXL |
| Unified Institutional Score Composite Signal | 42.4 / 100 (HOLD) | 40.0 / 100 (SELL) | Higher Composite | UXI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full UXI vs RXL Buy Guide
UXI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
RXL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither UXI nor RXL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.